EPINEPHRINE INJECTION

The Defense Logistics Agency awarded a delivery order under basic contract SPE2DX-25-D-8022 to Cardinal Health, Inc. (CAGE 00E55) for the supply of EPINEPHRINE INJECTION, identified by NSN 6505016674146 and NDC 54288-0103-10, with a total contract value of $160.68. The award, issued on July 14, 2026, is a single-line, fixed-price delivery order for two boxes at $80.34 per box, with no option quantities or variance permitted. The product must be delivered FOB Destination to USS CANBERRA LCS 30, Unit 10047 Box 1, FPO AP 96694, with the contractor responsible for all transportation costs and risks until acceptance at the final location. Inspection and acceptance are conducted by the Government at the destination, and the item must conform exactly to contract specifications without substitution. The award is consistent with a Lowest Price Technically Acceptable approach, typical for standardized medical supplies under DLA procedures. Cardinal Health, Inc. is certified as a Small Business, Small Disadvantaged Business, and Women-Owned Small Business, triggering compliance obligations under the Small Business Act and requiring accurate representation in the Dynamic Small Business Search database. Packaging and marking requirements mandate clear identification of the contract and delivery order numbers on all packages and associated documents, in accordance with DLAD PROC NOTE C19 and C20, though no specific preservation, barcoding, or military packaging standards are cited. Electronic invoicing via EDI is required, with payments processed through the Defense Finance and Accounting Service in Columbus, Ohio under accounting code 97X4930 5CBX 001 2620 S33189. The contracting officer is Lisa Quinn, with administrative oversight by Michelle Pampel at DLA Troop Support in Philadelphia. No formal Statement of Work, technical specifications, or FAR clauses were included in the available documentation, reflecting a streamlined procurement process focused on compliance with logistical, labeling, and delivery requirements for a sole-source pharmaceutical supply.